July 30 (SeeNews) - Bulgarian blue-chip veterinary drug maker Biovet said on Monday its first half net profit surged 91.4% on the year to 67,000 levs ($46,700/34,200 euro), while sales grew some 30%.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
